DMAAR

Drugs Made In America Acquisition Corp. Rights
DMAAR

19 hedge funds and large institutions have $2.53M invested in Drugs Made In America Acquisition Corp. Rights in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
19
Holders Change
+19
Holders Change %
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
CA
1
Crossingbridge Advisors
New York
$807K 850,000 +850,000 New
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$247K 1,900,000 +1,900,000 New
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$234K 1,800,000 +1,800,000 New
HCI
4
Harraden Circle Investments
New York
$195K 1,500,000 +1,500,000 New
GCL
5
Glazer Capital LLC
New York
$169K 1,300,000 +1,300,000 New
AC
6
Aristeia Capital
Connecticut
$117K 900,000 +900,000 New
MP
7
Mangrove Partners
Connecticut
$111K 850,000 +850,000 New
HCM
8
Highbridge Capital Management
New York
$111K 850,000 +850,000 New
WAM
9
Wolverine Asset Management
Illinois
$78.4K 603,038 +603,038 New
ASM
10
ATW SPAC Management
New York
$74.1K 570,000 +570,000 New
CS
11
Clear Street
New York
$71.5K 550,176 +550,176 New
CF
12
Cantor Fitzgerald
New York
$65K 500,000 +500,000 New
LP
13
LMR Partners
United Kingdom
$65K 500,000 +500,000 New
AA
14
AQR Arbitrage
Connecticut
$65K 500,000 +500,000 New
WA
15
Whitebox Advisors
Minnesota
$52K 400,000 +400,000 New
SSA
16
Schonfeld Strategic Advisors
New York
$26K 200,000 +200,000 New
MSU
17
Mizuho Securities USA
New York
$21K 209,897 +209,897 New
QL
18
Quarry LP
New York
$19.5K 150,000 +150,000 New
WAM
19
Warberg Asset Management
Illinois
$2.4K 18,443 +18,443 New